286 related articles for article (PubMed ID: 24527207)
1. Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.
Ripellino P; Fleetwood T; Cantello R; Comi C
Autoimmune Dis; 2014; 2014():201657. PubMed ID: 24527207
[TBL] [Abstract][Full Text] [Related]
2. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Mathis S; Vallat JM; Magy L
Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
[TBL] [Abstract][Full Text] [Related]
3. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
[TBL] [Abstract][Full Text] [Related]
4. A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man.
Patnaik AP; Mininni J; Porter NC; Morris NA
Case Rep Neurol; 2021; 13(1):73-77. PubMed ID: 33708097
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
Hahn AF
Neurology; 1998 Dec; 51(6 Suppl 5):S16-21. PubMed ID: 9851725
[TBL] [Abstract][Full Text] [Related]
6. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
7. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
11. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
12. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
13. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of chronic inflammatory demyelinating polyneuropathy (CIDP) in Europe and India: An exploratory study.
Svačina MKR; Mehndiratta MM; Vedeler CA; Sharma Y; Bobylev I; Sprenger A; Remke G; Wüstenberg H; Klein I; Joshi A; Lehmann HC
J Neurol Sci; 2021 Aug; 427():117507. PubMed ID: 34130060
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
Chang SJ; Lee JH; Kim SH; Lee JS; Kim HD; Kang JW; Lee YM; Kang HC
Korean J Pediatr; 2015 May; 58(5):194-8. PubMed ID: 26124851
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Aranami T; Yamamura T
Nihon Rinsho; 2013 May; 71(5):850-4. PubMed ID: 23777093
[TBL] [Abstract][Full Text] [Related]
17. Unconventional treatments for chronic inflammatory demyelinating polyneuropathy.
Rajabally YA
Neurodegener Dis Manag; 2017 Oct; 7(5):331-342. PubMed ID: 29043889
[TBL] [Abstract][Full Text] [Related]
18. Treatment Approaches for Atypical CIDP.
Menon D; Katzberg HD; Bril V
Front Neurol; 2021; 12():653734. PubMed ID: 33790853
[TBL] [Abstract][Full Text] [Related]
19. An update on the management of chronic inflammatory demyelinating polyneuropathy.
Gorson KC
Ther Adv Neurol Disord; 2012 Nov; 5(6):359-73. PubMed ID: 23139706
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.
Malik A; Berry R; Fung BM; Tabibian JH
Clin J Gastroenterol; 2021 Feb; 14(1):1-13. PubMed ID: 33146871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
